Cardinal Health (CAH) Stock Price

Cardinal Health Price

NYSE·CLOSED
225.75USD-2.77 (-1.22 %)
Market closed

Over the last 19 years Cardinal Health grew revenue by 5.6% annually, reaching 222.58 B USD. Earnings per share have grown at 5.5% per year over the last 19 years. For Cardinal Health, the net margin of 0.7% is broadly stable versus 0.4% a few years ago. At today's price the dividend yield works out to roughly 0.90%. The payout ratio is around 32% of earnings. The dividend has grown at 10.0% per year over the past 19 years. The consensus 12-month price target for Cardinal Health is 244.80 USD, about 8.4% above where the stock trades today. Of 22 analysts, 19 rate the stock a buy — an overall Buy consensus. The stock trades about 55% above its 52-week low.

Cardinal Health stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Cardinal Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cardinal Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cardinal Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Cardinal Health Stock Price History
DateCardinal Health Price
7/20/2026225.75 USD
7/17/2026228.52 USD
7/16/2026228.72 USD
7/15/2026224.94 USD
7/14/2026230.11 USD
7/13/2026233.82 USD
7/10/2026235.80 USD
7/9/2026233.77 USD
7/8/2026239.13 USD
7/7/2026239.71 USD
7/6/2026235.50 USD
7/2/2026238.94 USD
7/1/2026237.72 USD
6/30/2026237.56 USD
6/29/2026238.99 USD
6/26/2026237.92 USD
6/25/2026234.75 USD
6/24/2026233.01 USD
6/23/2026228.91 USD
6/22/2026224.59 USD
6/18/2026220.98 USD
6/17/2026226.35 USD
6/16/2026227.87 USD
6/15/2026224.75 USD
6/12/2026223.55 USD
6/11/2026221.85 USD
6/10/2026216.74 USD
6/9/2026212.67 USD
6/8/2026204.48 USD
6/5/2026206.72 USD
6/4/2026201.01 USD
6/3/2026195.98 USD
6/2/2026195.43 USD
6/1/2026195.37 USD
5/29/2026199.12 USD
5/28/2026199.07 USD
5/27/2026201.05 USD
5/26/2026200.45 USD
5/22/2026200.28 USD
5/21/2026199.90 USD
5/20/2026199.51 USD
5/19/2026200.37 USD
5/18/2026199.77 USD
5/15/2026195.20 USD
5/14/2026194.38 USD
5/13/2026186.35 USD
5/12/2026182.56 USD
5/11/2026182.50 USD
5/8/2026183.65 USD
5/7/2026185.28 USD
5/6/2026191.49 USD
5/5/2026197.00 USD
5/4/2026197.06 USD
5/1/2026195.24 USD
4/30/2026192.88 USD
4/29/2026202.82 USD
4/28/2026205.61 USD
4/27/2026202.34 USD
4/24/2026199.85 USD
4/23/2026204.72 USD
4/22/2026200.55 USD
4/21/2026204.92 USD
4/20/2026211.18 USD
4/17/2026213.99 USD
4/16/2026213.10 USD
4/15/2026211.83 USD
4/14/2026214.95 USD
4/13/2026214.18 USD
4/10/2026215.52 USD
4/9/2026215.80 USD
4/8/2026215.13 USD
4/7/2026212.77 USD
4/6/2026212.62 USD
4/2/2026214.05 USD
4/1/2026212.02 USD
3/31/2026211.31 USD
3/30/2026206.31 USD
3/27/2026206.58 USD
3/26/2026208.02 USD
3/25/2026214.02 USD
3/24/2026207.23 USD
3/23/2026206.62 USD
3/20/2026209.02 USD
3/19/2026214.22 USD
3/18/2026210.92 USD
3/17/2026216.02 USD
3/16/2026217.59 USD
3/13/2026217.08 USD
3/12/2026219.09 USD
3/11/2026214.97 USD
3/10/2026217.04 USD
3/9/2026222.28 USD
3/6/2026219.13 USD
3/5/2026216.02 USD
3/4/2026223.18 USD
3/3/2026226.35 USD
3/2/2026229.88 USD
2/27/2026229.23 USD
2/26/2026227.13 USD
2/25/2026226.18 USD
2/24/2026225.97 USD
2/23/2026224.82 USD
2/20/2026224.44 USD
2/19/2026222.76 USD
2/18/2026224.99 USD
2/17/2026225.58 USD
2/16/2026225.58 USD
2/13/2026220.79 USD
2/12/2026220.79 USD
2/11/2026215.06 USD
2/10/2026224.25 USD
2/9/2026220.27 USD
2/8/2026225.76 USD
2/6/2026226.32 USD
2/5/2026226.32 USD
2/4/2026227.18 USD
2/3/2026206.85 USD
2/2/2026218.00 USD
2/1/2026218.93 USD
1/30/2026214.88 USD
1/29/2026214.88 USD
1/28/2026211.23 USD
1/27/2026210.39 USD
1/26/2026214.04 USD
1/25/2026210.93 USD
1/23/2026208.33 USD
1/22/2026208.33 USD
1/21/2026206.89 USD
1/20/2026208.47 USD
1/19/2026210.37 USD
1/16/2026212.45 USD
1/15/2026212.45 USD
1/14/2026213.46 USD
1/13/2026213.56 USD
1/12/2026208.26 USD
1/11/2026202.52 USD
1/9/2026201.11 USD
1/8/2026201.11 USD
1/7/2026202.49 USD
1/6/2026207.19 USD
1/5/2026208.48 USD
1/4/2026205.45 USD
1/2/2026205.72 USD
1/1/2026205.72 USD
12/31/2025205.50 USD
12/30/2025205.50 USD
12/29/2025207.21 USD
12/28/2025207.38 USD
12/26/2025208.29 USD
12/25/2025208.29 USD
12/24/2025207.54 USD
12/23/2025207.54 USD
12/22/2025207.37 USD
12/21/2025205.20 USD
12/19/2025202.95 USD
12/18/2025202.95 USD
12/17/2025199.10 USD
12/16/2025198.44 USD
12/15/2025197.89 USD
12/14/2025199.96 USD
12/12/2025198.18 USD
12/11/2025198.18 USD
12/10/2025198.32 USD
12/9/2025198.21 USD
12/8/2025198.00 USD
12/7/2025198.88 USD
12/5/2025198.83 USD
12/4/2025198.83 USD
12/3/2025199.19 USD
12/2/2025199.71 USD
12/1/2025205.13 USD
11/30/2025208.00 USD
11/28/2025212.26 USD
11/27/2025212.26 USD
11/26/2025213.14 USD
11/25/2025213.14 USD
11/24/2025213.73 USD
11/23/2025211.20 USD
11/21/2025209.48 USD
11/20/2025209.48 USD
11/19/2025207.90 USD
11/18/2025207.52 USD
11/17/2025206.97 USD
11/16/2025206.18 USD
11/14/2025205.37 USD
11/13/2025205.37 USD
11/12/2025206.06 USD
11/11/2025204.32 USD
11/10/2025204.81 USD
11/9/2025205.43 USD
11/7/2025203.67 USD
11/6/2025203.67 USD
11/5/2025197.99 USD
11/4/2025196.79 USD
11/3/2025195.34 USD
11/2/2025190.22 USD
10/31/2025190.77 USD
10/30/2025190.77 USD
10/29/2025189.84 USD
10/28/2025164.47 USD
10/27/2025162.79 USD
10/26/2025163.80 USD
10/23/2025161.89 USD
10/22/2025159.16 USD
10/21/2025159.52 USD
10/20/2025158.68 USD
10/19/2025157.27 USD
10/16/2025156.41 USD
10/15/2025153.27 USD
10/14/2025155.67 USD
10/13/2025154.19 USD
10/12/2025154.31 USD
10/9/2025156.88 USD
10/8/2025157.21 USD
10/7/2025157.77 USD
10/6/2025156.65 USD
10/5/2025155.19 USD
10/2/2025154.46 USD
10/1/2025158.46 USD
9/30/2025157.93 USD
9/29/2025156.96 USD
9/28/2025154.57 USD
9/25/2025153.71 USD
9/24/2025148.96 USD
9/23/2025154.58 USD
9/22/2025154.62 USD
9/21/2025147.47 USD
9/18/2025149.60 USD
9/17/2025150.04 USD
9/16/2025148.68 USD
9/15/2025148.37 USD
9/14/2025150.27 USD
9/11/2025152.24 USD
9/10/2025152.47 USD
9/9/2025149.29 USD
9/8/2025150.94 USD
9/7/2025150.28 USD
9/4/2025149.56 USD
9/3/2025149.34 USD
9/2/2025150.56 USD
9/1/2025149.55 USD
8/28/2025148.78 USD
8/27/2025149.51 USD
8/26/2025149.24 USD
8/25/2025147.49 USD
8/24/2025146.04 USD
8/21/2025148.10 USD
8/20/2025151.57 USD
8/19/2025152.95 USD
8/18/2025149.02 USD
8/17/2025149.73 USD
8/14/2025149.61 USD
8/13/2025150.22 USD
8/12/2025148.12 USD
8/11/2025146.30 USD
8/10/2025157.66 USD
8/7/2025157.41 USD
8/6/2025153.41 USD
8/5/2025156.60 USD
8/4/2025158.24 USD
8/3/2025158.62 USD
7/31/2025156.00 USD
7/30/2025155.22 USD
7/29/2025157.90 USD
7/28/2025157.39 USD
7/27/2025156.33 USD
7/24/2025157.14 USD
7/23/2025158.28 USD
7/22/2025157.76 USD
Access this data via the Eulerpool API
Get Free API Key

Cardinal Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
205.01 B USD
1.77 B USD
261.00 M USD
Jan 1, 2024
226.83 B USD
2.15 B USD
852.00 M USD
Jan 1, 2025
222.58 B USD
2.48 B USD
1.56 B USD
Jan 1, 2026 (e)
261.17 B USD
3.43 B USD
2.45 B USD
Jan 1, 2027 (e)
284.54 B USD
3.77 B USD
2.76 B USD
Jan 1, 2028 (e)
306.45 B USD
4.11 B USD
3.08 B USD
Jan 1, 2029 (e)
333.04 B USD
4.64 B USD
3.56 B USD
Jan 1, 2030 (e)
357.61 B USD
5.01 B USD
3.92 B USD

Cardinal Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 22, 2026, 11:40 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
102.53121.55129.98136.81145.53152.92162.47181.36205.01226.83222.58261.17284.54306.45333.04357.61
12.5718.556.945.266.385.086.2411.6313.0410.64-1.8717.348.957.708.687.38
5.575.385.035.254.704.494.173.613.363.273.673.673.673.673.673.67
5.716.546.547.186.836.876.786.556.897.418.179.5810.4411.2512.2213.12
2.382.542.382.011.821.781.821.681.772.152.483.433.774.114.645.01
2.322.091.831.471.251.171.120.920.870.951.121.311.321.341.391.40
1.221.431.290.261.36-3.700.61-0.930.260.851.562.452.763.083.563.92
4.2017.45-9.74-80.12432.42-371.17-116.53-252.70-127.97226.4483.2256.6312.8411.7815.4710.03
1.502.182.301.891.921.941.961.982.001.512.032.042.062.08––
-10.1845.335.50-17.831.591.041.031.021.01-24.5034.440.490.980.97––
335.00330.00320.00313.00301.00293.00294.00279.00262.00247.00242.00242.00242.00242.00242.00242.00
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Cardinal Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cardinal Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cardinal Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Cardinal Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cardinal Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Cardinal Health stock margins

The Cardinal Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cardinal Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cardinal Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
4.17 %
1.12 %
0.38 %
Jan 1, 2022
3.61 %
0.92 %
-0.51 %
Jan 1, 2023
3.36 %
0.87 %
0.13 %
Jan 1, 2024
3.27 %
0.95 %
0.38 %
Jan 1, 2025
3.67 %
1.12 %
0.70 %
Jan 1, 2026 (e)
3.67 %
1.31 %
0.94 %
Jan 1, 2027 (e)
3.67 %
1.32 %
0.97 %
Jan 1, 2028 (e)
3.67 %
1.34 %
1.01 %

Cardinal Health Stock Revenue, EBIT, Earnings per Share

The Cardinal Health earnings per share therefore indicates how much revenue Cardinal Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
552.61 USD
6.18 USD
2.08 USD
Jan 1, 2022
650.05 USD
6.01 USD
-3.34 USD
Jan 1, 2023
782.49 USD
6.77 USD
1.00 USD
Jan 1, 2024
918.33 USD
8.70 USD
3.45 USD
Jan 1, 2025
919.74 USD
10.26 USD
6.45 USD
Jan 1, 2026 (e)
1,079.20 USD
14.18 USD
10.10 USD
Jan 1, 2027 (e)
1,175.78 USD
15.57 USD
11.40 USD
Jan 1, 2028 (e)
1,266.32 USD
16.97 USD
12.75 USD

Cardinal Health business model & stock analysis

Cardinal Health Inc. is an American company operating in the healthcare sector. It was founded in 1971 and is headquartered in Dublin, Ohio. Cardinal Health's business model is based on manufacturing and distributing medical products and services that cover the entire spectrum of healthcare. The company is divided into three business segments: pharmaceutical, medical, and laboratory products. Cardinal Health offers a wide range of products, including prescription medications, medical devices, and laboratory supplies. It has become a major supplier to healthcare providers worldwide.

Cardinal Health SWOT Analysis

Strengths

1. Extensive distribution network facilitating efficient supply chain management.

2. Diversified product portfolio including pharmaceuticals, medical and surgical products.

3. Strong brand reputation and recognition in the healthcare industry.

4. Well-established relationships with various healthcare providers.

5. Ability to leverage technology to enhance operational efficiency.

Weaknesses

1. Dependence on a limited number of large customers for a significant portion of revenue.

2. Vulnerability to changes in government regulations and reimbursement policies.

3. Reliance on external suppliers for raw materials and finished products.

4. High competition within the healthcare distribution industry.

5. Occasional product recalls impacting customer trust.

Opportunities

1. Growing demand for healthcare services due to aging population and increasing chronic diseases.

2. Expansion into emerging markets with evolving healthcare systems.

3. Strategic partnerships and acquisitions to enhance market presence and diversify offerings.

4. Adoption of advanced technologies and data analytics for improved efficiency and patient care.

5. Increasing focus on personalized medicine and home healthcare.

Threats

1. Intense competition from other healthcare distributors and manufacturers.

2. Cost containment measures in the healthcare industry impacting profit margins.

3. Economic downturns affecting customer spending on healthcare products.

4. Legal and regulatory risks associated with the healthcare industry.

5. Potential disruptions in the global supply chain due to geopolitical events or natural disasters.

Cardinal Health Segments

Cardinal Health Revenue by Segment (1/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Medical
Details
Date
Total Segment Profit
Pharmaceutical
Medical
Corporate
Jan 1, 2012
107.57 B USD
97.93 B USD
9.64 B USD
-15.00 M USD
Jan 1, 2013
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD
11.40 B USD
0.00 USD

Cardinal Health Revenue by Segment (2/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Pharmaceutical
Details
Date
Pharmaceutical
Jan 1, 2012
0.00 USD
Jan 1, 2013
91.10 B USD
Jan 1, 2014
80.11 B USD
Jan 1, 2015
91.12 B USD

Cardinal Health Revenue by Segment (3/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Medical
Corporate
Details
Date
Medical
Corporate
Jan 1, 2012
0.00 USD
0.00 USD
Jan 1, 2013
0.00 USD
0.00 USD
Jan 1, 2014
10.96 B USD
0.00 USD
Jan 1, 2015
0.00 USD
20.00 M USD

Cardinal Health Revenue by Segment (4/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Reportable Segments
Medical
Corporate
Details
Date
Reportable Segments
Medical
Corporate
Jan 1, 2012
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2013
0.00 USD
10.06 B USD
0.00 USD
Jan 1, 2014
0.00 USD
0.00 USD
12.00 M USD
Jan 1, 2015
102.51 B USD
0.00 USD
0.00 USD

Cardinal Health Revenue by Segment (5/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Reportable Segments
Corporate
Details
Date
Reportable Segments
Corporate
Jan 1, 2012
0.00 USD
0.00 USD
Jan 1, 2013
0.00 USD
-64.00 M USD
Jan 1, 2014
91.07 B USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD

Cardinal Health Revenue by Segment (6/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Reportable Segment
Details
Date
Reportable Segment
Jan 1, 2012
0.00 USD
Jan 1, 2013
101.16 B USD
Jan 1, 2014
0.00 USD
Jan 1, 2015
0.00 USD

Cardinal Health Revenue by Region

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

United States
International
Other Countries
Details
Date
United States
International
Other Countries
Jan 1, 2018
132.53 B USD
4.28 B USD
0.00 USD
Jan 1, 2019
141.48 B USD
0.00 USD
4.07 B USD
Jan 1, 2020
148.71 B USD
4.23 B USD
0.00 USD
Jan 1, 2021
157.76 B USD
0.00 USD
4.73 B USD
Jan 1, 2022
176.86 B USD
0.00 USD
4.52 B USD
Jan 1, 2023
200.38 B USD
0.00 USD
4.64 B USD
Jan 1, 2024
225.23 B USD
0.00 USD
1.68 B USD
Jan 1, 2025
220.99 B USD
0.00 USD
1.67 B USD

Cardinal Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Cardinal Health historical P/E ratio, EBIT multiple, and P/S ratio

Cardinal Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Cardinal Health shares outstanding

The number of shares of Cardinal Health was 242 M in 2025. This indicates how many shares Cardinal Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
294.00 M Stocks
Jan 1, 2022
279.00 M Stocks
Jan 1, 2023
262.00 M Stocks
Jan 1, 2024
247.00 M Stocks
Jan 1, 2025
242.00 M Stocks
Jan 1, 2026 (e)
242.00 M Stocks
Jan 1, 2027 (e)
242.00 M Stocks
Jan 1, 2028 (e)
242.00 M Stocks

Cardinal Health stock splits

In Cardinal Health's history, there have been no stock splits.

Cardinal Health Dividend History

38 years of dividend payments

YearAnnual DividendYoY ChangePayments
20261.02USDYTD—2×
Jan 2, 20260.51USD 0.0%1/2
Apr 1, 20260.51USD 0.0%2/2
20252.03USD↑ 34.4%4×
Jan 2, 20250.51USD 0.0%1/4
Apr 1, 20250.51USD 0.0%2/4
Jul 1, 20250.51USD↑ 1.0%3/4
Oct 1, 20250.51USD 0.0%4/4
20241.51USD↓ 24.3%3×
20232.00USD↑ 1.0%4×
20221.98USD↑ 1.0%4×
20211.96USD↑ 1.0%4×
20201.94USD↑ 1.0%4×
20191.92USD↑ 1.5%4×
20181.89USD↓ 17.7%4×
20172.30USD↑ 5.3%5×

Cardinal Health dividend history and estimates

In 2025, Cardinal Health paid a dividend amounting to 2.03 USD. Dividend means that Cardinal Health distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.96 USD
0.00 USD
Jan 1, 2022
1.98 USD
0.00 USD
Jan 1, 2023
2.00 USD
0.00 USD
Jan 1, 2024
1.51 USD
0.00 USD
Jan 1, 2025
2.03 USD
0.00 USD
Jan 1, 2026 (e)
1.53 USD
0.51 USD
Jan 1, 2027 (e)
0.00 USD
2.06 USD
Jan 1, 2028 (e)
0.00 USD
2.08 USD

Cardinal Health dividend payout ratio

In 2025, Cardinal Health had a payout ratio of 31.51%. The payout ratio indicates the percentage of the company's profits that Cardinal Health distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
94.15 %
Jan 1, 2022
-59.22 %
Jan 1, 2023
199.75 %
Jan 1, 2024
43.83 %
Jan 1, 2025
31.51 %
Jan 1, 2026 (e)
20.22 %
Jan 1, 2027 (e)
18.09 %
Jan 1, 2028 (e)
16.35 %

Current Cardinal Health forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
7.62 %
Buy86.36 % (19)
Hold13.64 % (3)
Sell0.00 % (0)
12M Price Target
244.80
Last Price
225.75
Currency
USD
12M Return Potential
8.44 %
LTM Return
0 %

Cardinal Health Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
4/30/20262.80USD62.33 BUSD2026 Q3
2/5/20262.38USD64.79 BUSD2026 Q2
8/12/20252.06USD61.48 BUSD2025 Q4
5/2/20241.91USD56.47 BUSD2024 Q3
1/31/20241.61USD57.63 BUSD2024 Q2
8/9/20231.54USD53.15 BUSD2023 Q4
5/3/20231.53USD50.31 BUSD2023 Q3
2/1/20231.19USD50.96 BUSD2023 Q2
11/4/20220.95USD48.91 BUSD2023 Q1
8/11/20221.19USD45.38 BUSD2022 Q4
...

EESG©

Eulerpool ESG Scorecard© for the Cardinal Health stock

90/100
93
Environment
85
Social
92
Governance
E

Environment

20
Scope 1 - Direct Emissions160,150
Scope 2 - Indirect emissions from purchased energy205,710
Scope 3 - Indirect emissions within the value chain22,437,666
Total CO₂ emissions365,860
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees51.1
Percentage of women in management—
Percentage of Asian employees9.7
Share of Asian management8.675
Percentage of Hispanic/Latino employees19.4
Hispano/Latino Management share8.675
Percentage of Black employees18.2
Black Management Share9.305
Percentage of white employees49.3
White Management Share70.708
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Cardinal Health shareholder structure

% Name
12.58980%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
6.06919%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
5.23683%
State Street Investment Management (US)
State Street Investment Management (US)
2.64010%
Geode Capital Management, L.L.C.
Geode Capital Management, L.L.C.
2.22268%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
2.07009%
BlackRock Financial Management, Inc.
BlackRock Financial Management, Inc.
...

Cardinal Health Executives and Management Board

JH

Mr. Jason Hollar

(52)

Chief Executive Officer, Director · since 2020

Compensation18.98 M USD
AA

Mr. Aaron Alt

(53)

Chief Financial Officer

Compensation6.21 M USD
DW

Ms. Deborah Weitzman

(60)

Chief Executive Officer of Pharmaceutical and Specialty Solutions Segment

Compensation5.51 M USD
JM

Ms. Jessica Mayer

(56)

Chief Legal and Compliance Officer

Compensation4.93 M USD
SM

Mr. Stephen Mason

(54)

Corporate Executive - GMPD segment

Compensation4.75 M USD

Cardinal Health Supply Chain

Cardinal Health Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
30 companies
#Name1M3M6M1Y2YTrend
1
Bristol-Myers Squibb
Supplier
-0.11
0.71
0.90
0.85
0.63
2
Antares Pharma
Supplier
0.28
0.37
0.72
0.72
0.57
3
Amgen
Supplier
-0.62
0.75
0.88
0.90
0.56
4
Lantheus Holdings
Supplier
0.29
0.45
0.80
0.60
0.36
#Name1M3M6M1Y2YTrend
1
Apria, Inc.
-0.49
0.26
0.51
0.02
—
2
Virtusa Corporation
Supplier
0.12
0.63
0.62
—
—
3
Roche Holding AG
Supplier
0.82
0.49
-0.09
-0.15
—
4
Zhonghong Pulin Medical Products A
Supplier
0.50
0
-0.56
-0.09
—
5
Organon
Supplier
-0.51
-0.45
0.46
0.01
—

Frequently asked questions about Cardinal Health

The business model of Cardinal Health Inc. revolves around providing essential services and solutions to healthcare organizations. As a renowned healthcare services and products company, Cardinal Health operates through various segments, including Pharmaceutical and Medical segments. The company distributes pharmaceuticals, medical and surgical products, along with offering innovative solutions and cost-effective services to healthcare providers. Cardinal Health also focuses on improving the efficiency and effectiveness of healthcare delivery, ultimately benefiting patients and healthcare professionals worldwide. With its extensive network and strong partnerships, Cardinal Health continues to excel in the healthcare industry and contribute to the overall well-being of communities.

All fundamentals and in-depth analysis of Cardinal Health

Our stock analysis for Cardinal Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cardinal Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Cardinal Health Stock
Cardinal Health Revenue→
Cardinal Health Stock
Cardinal Health Net Income→
Cardinal Health Stock
Cardinal Health P/E→
Cardinal Health Stock
Cardinal Health P/S→
Cardinal Health Stock
Cardinal Health EBIT→
Cardinal Health Stock
Cardinal Health Dividend→
Cardinal Health Stock
Cardinal Health Directors Dealings→
Cardinal Health Stock
Cardinal Health Stocks→
Cardinal Health Stock
Cardinal Health Market capitalization→
Cardinal Health Stock
Cardinal Health Debt→
Cardinal Health Stock
Cardinal Health Liabilities→
Cardinal Health Stock
Cardinal Health Equity→
Cardinal Health Stock
Cardinal Health AAQS→
Cardinal Health Stock
Cardinal Health Employees→
Cardinal Health Stock
Cardinal Health ROE→
Cardinal Health Stock
Cardinal Health ROA→
Cardinal Health Stock
Cardinal Health ROCE→
Cardinal Health Stock
Cardinal Health News→
Cardinal Health Stock
Cardinal Health Analyst Price Targets→

Health Stocks

Cardio Diagnostics HoldingsCardiff OncologyCardioComm SolutionsCardaxCardioGenics HoldingsCaptor CapitalCardiol TherapeuticsCapstone HoldingCare Service CoCapsoVisionCare TwentyoneCapricor TherapeuticsAll Stocks A–Z →